Christine Lacabaratz

13PUBLICATIONS
55CO-AUTHORS
Epidemiological methodsEconometric and statistical methodsInnate immunityMajor global burdens of diseaseMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 03, 2024
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases.

Aurélie Wiedemann, Edouard Lhomme, Mélanie Huchon

|Jul 16, 2024
Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial.

Christine Lacabaratz, Mélany Durand, Aurélie Wiedemann

|Jun 24, 2022
NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in Africans.

Helen R Wagstaffe, Omu Anzala, Hannah Kibuuka

|May 25, 2022
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.

Laura Richert, Jean-Daniel Lelièvre, Christine Lacabaratz

|May 02, 2022
Profound Defect of Amphiregulin Secretion by Regulatory T Cells in the Gut of HIV-Treated Patients.

Mubashira Tariq, Sébastien Gallien, Mathieu Surenaud

|Jan 11, 2022
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.

Zacchaeus Anywaine, Houreratou Barry, Omu Anzala

Pageof 3

Frequent Collaborators

9 joint publications

Yves Lévy

5 joint publications

Aurélie Wiedemann

5 joint publications

Rodolphe Thiébaut

4 joint publications

Laura Richert